Effects of iloprost on calvarial sutures

Journal of Craniofacial Surgery

Volumn 19, Issue 6, 2008, Pages 1472-1480

  Tunçbilek, Gökhan ^a   Korkusuz, Petek ^a   Özgür, Figen ^b  

^a Department of Plastic and Reconstructive Surgery ^*  (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cranial suture; Iloprost; Prostacyclin

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DEXAMETHASONE; ILOPROST; TRANSFORMING GROWTH FACTOR BETA; FIBROBLAST GROWTH FACTOR 2; GLUCOCORTICOID; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE REMODELING; CONTROL GROUP; CONTROLLED STUDY; CORTICAL BONE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EVALUATION; FRONTAL BONE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKULL SUTURE; STAINING; TREATMENT DURATION; ANIMAL; BONE DEVELOPMENT; CEPHALOMETRY; COMPARATIVE STUDY; CRANIAL SUTURE; FIBROBLAST; INTRAPERITONEAL DRUG ADMINISTRATION; MESODERM; MICROTOMY; NEWBORN; OSTEOBLAST; PATHOLOGY; SKULL; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW; BONE REMODELING; CEPHALOMETRY; CRANIAL SUTURES; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FRONTAL BONE; GLUCOCORTICOIDS; ILOPROST; INJECTIONS, INTRAPERITONEAL; MESODERM; MICROTOMY; OSTEOBLASTS; OSTEOGENESIS; PARIETAL BONE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA; VASODILATOR AGENTS;

EID: 63249101186     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e318188a31b     Document Type: Article

References (32)

1. Cohen MM. Sutural Pathology. In: Cohen MM, Mac Lean RE, eds. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford University Press, 2000:51-68.
2. U3eda K, Saito A, Nakano H, et al. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 1980;97:834-836.
3. Sone K, Tashiro M, Fujinaga T, et al. Long-term low-dose prostaglandin E1 administration. J Pediatr 1980;97:866-867.
4. Ringel RE, Brenner JI, Haney PJ, et al. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology 1982;142:657-658.
5. 2 therapy in two newborn infants. J Pediatr 1984;105:72-74.
6. Beitke A, Stein J. Pseudo-widening of cranial sutures as a feature of long-term prostaglandin E1 therapy. Pediatr Radiol 1986;16:7-58.
7. Naeije R, Huez S. Expert opinion on available options treating pulmonary arterial hypertension. Expert Opin Pharmacother 2007;8:2247-2265.
8. Elliot CA, Stewart P, Webster VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005;26:168-173.
9. Huang S, DeSantis ER. Treatment of pulmonary arterial hypertension in pregnancy. Am J Health Syst Pharm 2007; 64:1922-1926.
10. Ferrara F, Meli F, Raimondi F, et al. The treatment of venous leg ulcers: a new therapeutic use of iloprost. Ann Surg 2007; 246:860-865.
11. de Donato G, Gussoni G, de Donato G, et al. Ilaill Study Group. Acute limb ischemia in elderly patients: can iloprost be useful as an adjuvant to surgery? Results from the ILAILL study. Eur J Vasc Endovasc Surg 2007;34:194-198.
12. Mooney MP, Kraus EM, Bardach J, et al. Skull preparation using the enzyme active detergent technique. Anat Rec 1982;202:125-129.
13. Moss ML. Growth of the calvaria in the rat. Am J Anat 1954;94:333-358.
14. An YH, Friedman RJ, eds. Animal models in orthopedic research. Raton: CRC Press, 1999:251-259.
15. Keskin D, Tezcaner A, Korkusuz P, et al. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair. Biomaterials 2005;26:4023-4034.
16. Korkusuz P, Da?deviren A, Azan E. "Immunophenotypic analysis of human spleen compartments," Ann Anatomy 2002;184:431-441.
17. Farr D, Pochal W, Brown M, et al. Effects of prostaglandins on rat calvarial bone cell calcium. Arch Oral Biol 1984;29:885-891.
18. Rawlinson SC, El-Haj AJ, Minter SL, et al. Loading-related increases in prostaglandin production in cores of adult canine cancellous bone in vitro: a role for prostacyclin in adaptive bone remodeling? J Bone Miner Res 1991;6:1345-1351.
19. Rawlinson SC, Mohan S, Baylink DJ, et al. Exogenous prostacyclin, but not prostaglandin E2, produces similar responses in both G6PD activity and RNA production as mechanical loading, and increases IGF-II release, in adult cancellous bone in culture. Calcif Tissue Int 1993;53:324-329.
20. 2): a potential mediator of c-fos expression induced by hydrostatic pressure in osteoblastic cells. Eur J Clin Invest 1996;26:544-548.
21. Conaway HH, Grigorie D, Lerner UH. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids, hydrocortisone and dexamethasone. J Bone Min Res 1996;11:1419-1429.
22. Canalis E. Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae. Calcif Tissue Int 1984;36:158-166.
23. Lukert B, Mador A, Raisz LG, et al. The role of DNA synthesis in the responses of fetal rat calvariae to cortisol. J Bone Miner Res 1991;6:453-460.
24. Conaway HH, Grigorie D, Lerner UH. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvaria stimulated by peptide and steroid-like hormones. J Endocrinol 1997;155:513-521.
25. Woitge HW, Kream BE. Calvariae from fetal mice with disrupted Igf1 gene have reduced rates of collagen synthesis but maintain responsiveness to glucocorticoids. J Bone Miner Res 2000;15:1956-1964.
26. Opperman LA, Nolen AA, Ogle RC. TGF b1, TGF b2, and TGF β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 1997;12:301-310.
27. Roth DA, Longaker MT, McCarthy JG, et al. Studies in cranial suture biology. Part I: increased immunreactivity for TGF isoforms (β1, β2, β3) during rat cranial suture fusion. J Bone Miner Res 1997;12:311-321.
28. Roth DA, Gold LI, Han VKM, et al. Transforming growth factor β1, β2, and β3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg 1997;99:300-309.
29. Cohen MM. TGF β and sutural pathology In: Cohen MM, Mac Lean RE, eds. Craniosynostosis: diagnosis, evaluation, and management. New York: Oxford University Press, 2000:69-76.
30. Cohen MM. Fibroblast growth factor receptor mutations. In: Cohen MM, Mac Lean RE, eds. Craniosynostosis: diagnosis, evaluation, and management. New York: Oxford University Press, 2000:77-94.
31. Mehrara BJ, Mackool RJ, McCarthy JG, et al. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg 1998;102:1805-1817.
32. Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650-1657.